Free shipping on all orders over $ 500
Inhibitors
| Cat.No. | Name | Information |
|---|---|---|
| M10228 | Caspase-9 Inhibitor III | Caspase-9 Inhibitor III is a potent and irreversible inhibitor of caspase-9. |
| M9486 | N-BOC-D-FMK | N-BOC-D-FMK is a Caspase-3 inhibitor. |
| M9293 | Z-Asp-CH2-DCB | Z-Asp-CH2-DCB is an irreversible, cell permeable broad-spectrum caspase inhibitor, with IC50 values of 1.1 and 4.1 μM for caspase-3 and caspase-6 respectively. |
| M9065 | Ac-DEVD-CHO | Ac-DEVD-CHO is a specific inhibitor of Caspase-3 with a Ki value of 230 pM. |
| M6237 | CA-074 | CA-074 is a potent inhibitor of cathepsin B with a Ki of 2 to 5 nM. |
| M6233 | Z-YVAD-FMK | Z-YVAD-FMK is a synthetic peptide that irreversibly inhibits activity of caspase-1. The inhibitor is designed as a methyl ester to facilitate cell permeability. The product can be used for both in vitro and in vivo studies. |
| M6232 | Z-LEED-FMK | Z-LEED-FMK is caspase-13 inhibitor. |
| M6231 | Z-VAD(OH)-FMK | Z-VAD-FMK (Caspase Inhibitor VI) is an irreversible pan-caspase inhibitor. |
| M6128 | BOC-D-FMK | Boc-D-FMK is a cell-permeable, irreversible and broad spectrum caspase inhibitor; inhibits apoptosis stimulated by TNF-α with an IC50 of 39 µM. |
| M5612 | Emricasan | Emricasan is a potent irreversible pan-caspase inhibitor. |
| M5215 | NQDI-1 | NQDI-1 is a selective inhibitor of ASK1 with a Ki of 500 nM. |
| M4705 | Asperosaponin-VI | Asperosaponin-VI induces osteoblast differentiation through BMP‐2/p38 and ERK1/2 pathway. Asperosaponin Ⅵ inhibits apoptosis in hypoxia-induced cardiomyocyte by increasing the Bcl-2/Bax ratio and decreasing active caspase-3 expression, as well as enhancing of p-Akt and p-CREB. |
| M4070 | (S)Ginsenoside-Rh2 | (S)Ginsenoside-Rh2 is isolated from the root of Ginseng, induces the activation of caspase-8 and caspase-9. |
| M3532 | VX-765 (Belnacasan) | VX-765 is a potent and selective inhibitor of caspase-1 with Ki of 0.8 nM. |
| M3143 | Z-VAD-FMK | Z-VAD-FMK is a cell-permeable, irreversible pan-caspase inhibitor which blocks all features of apoptosis. |
| M3136 | Z-IETD-FMK | Z-IETD-FMK is a specific Caspase-8 inhibitor. |
| M3134 | Z-DEVD-FMK | Z-DEVD-FMK is a specific, irreversible Caspase-3 inhibitor, and also shows potent inhibition on caspase-6, caspase-7, caspase-8, and caspase-10. |
| M2972 | Q-VD-OPh | Q-VD-OPh is a potent pan-caspase inhibitor with IC50 ranging from 25 to 400 nM for caspases 1, 3, 8, and 9, showing inhibitory effects on terminal caspase activation, substrate cleavage, and DNA ladder formation associated with apoptosis. |
| M2551 | LY573636 (Tasisulam) | LY573636 is a novel anticancer agent that induces apoptosis through the intrinsic pathway and has antiangiogenic activity in preclinical models. |
| M2403 | Apoptosis Activator 2 | Apoptosis Activator 2 strongly induces caspase-3 activation, PARP cleavage, and DNA fragmentation which leads to the destruction of cells (Apaf-1 dependent) with IC50 of ~4 μM, inactive to HMEC, PREC, or MCF-10A cells. |
| M1867 | PAC-1 | PAC-1 is a procaspase-activating compound; activates procaspase-3 to produce caspase-3 (EC50 = 0.22 μM). |
Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.
